These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19406046)

  • 1. Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation.
    Bryant J; Cooper K; Picot J; Clegg A; Roderick P; Rosenberg W; Patch C
    Health Technol Assess; 2009 Apr; 13(23):iii, ix-xi, 1-126. PubMed ID: 19406046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A decision analysis model for diagnostic strategies using DNA testing for hereditary haemochromatosis in at risk populations.
    Cooper K; Bryant J; Picot J; Clegg A; Roderick PR; Rosenberg WM; Patch C
    QJM; 2008 Aug; 101(8):631-41. PubMed ID: 18522976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of the clinical validity and clinical utility of DNA testing for hereditary haemochromatosis type 1 in at-risk populations.
    Bryant J; Cooper K; Picot J; Clegg A; Roderick P; Rosenberg W; Patch C
    J Med Genet; 2008 Aug; 45(8):513-8. PubMed ID: 18310265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers.
    Bassett ML; Leggett BA; Halliday JW; Webb S; Powell LW
    J Hepatol; 1997 Sep; 27(3):517-24. PubMed ID: 9314130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?
    Cadet E; Capron D; Gallet M; Omanga-Léké ML; Boutignon H; Julier C; Robson KJ; Rochette J
    J Med Genet; 2005 May; 42(5):390-5. PubMed ID: 15863667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for hereditary haemochromatosis within families and beyond.
    McCune CA; Ravine D; Worwood M; Jackson HA; Evans HM; Hutton D
    Lancet; 2003 Dec; 362(9399):1897-8. PubMed ID: 14667749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial aspects of DNA testing for hereditary hemochromatosis in at-risk individuals: a systematic review.
    Picot J; Bryant J; Cooper K; Clegg A; Roderick P; Rosenberg W; Patch C
    Genet Test Mol Biomarkers; 2009 Feb; 13(1):7-14. PubMed ID: 19309267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-based screening for hereditary haemochromatosis. I: Technical performance, costs and clinical relevance of a German pilot study.
    Stuhrmann M; Strassburg C; Schmidtke J
    Eur J Hum Genet; 2005 Jan; 13(1):69-78. PubMed ID: 15483651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force.
    Whitlock EP; Garlitz BA; Harris EL; Beil TL; Smith PR
    Ann Intern Med; 2006 Aug; 145(3):209-23. PubMed ID: 16880463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
    Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
    Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping.
    Adams PC; Valberg LS
    Am J Gastroenterol; 1999 Jun; 94(6):1593-600. PubMed ID: 10364030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis.
    Hickman PE; Hourigan LF; Powell LW; Cordingley F; Dimeski G; Ormiston B; Shaw J; Ferguson W; Johnson M; Ascough J; McDonell K; Pink A; Crawford DH
    Gut; 2000 Mar; 46(3):405-9. PubMed ID: 10673305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms.
    Gagné G; Reinharz D; Laflamme N; Adams PC; Rousseau F
    Clin Genet; 2007 Jan; 71(1):46-58. PubMed ID: 17204047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of the Cys282Tyr HFE mutation facilitates an improved diagnostic service for hereditary haemochromatosis in South Africa.
    de Villiers JN; Hillerman R; de Jong G; Langenhoven E; Rossouw H; Marx MP; Kotze MJ
    S Afr Med J; 1999 Mar; 89(3):279-82. PubMed ID: 10226674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and effectiveness of different methods of earwax removal: a systematic review and economic evaluation.
    Clegg AJ; Loveman E; Gospodarevskaya E; Harris P; Bird A; Bryant J; Scott DA; Davidson P; Little P; Coppin R
    Health Technol Assess; 2010 Jun; 14(28):1-192. PubMed ID: 20546687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary haemochromatosis.
    Janssen MC; Swinkels DW
    Best Pract Res Clin Gastroenterol; 2009; 23(2):171-83. PubMed ID: 19414144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-minimization analysis of genetic testing versus clinical screening of at-risk relatives for familial adenomatous polyposis.
    Chikhaoui Y; Gélinas H; Joseph L; Lance JM
    Int J Technol Assess Health Care; 2002; 18(1):67-80. PubMed ID: 11987443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.